Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial

This publication has 19 references indexed in Scilit:

• Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde Cholangiopancreatography
  New England Journal of Medicine, 1996
• A comparison of nonionic versus ionic contrast media: Results of a prospective, multicenter study
  Gastrointestinal Endoscopy, 1995
• Post-ERCP pancreatitis: Randomized, prospective study comparing a low- and high-osmolality contrast agent
  Gastrointestinal Endoscopy, 1994
• Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
  Gut, 1992
• ERCP- and Endoscopic Sphincterotomy-Induced Pancreatitis
  Pancreas, 1991
• The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography
  Gastrointestinal Endoscopy, 1991
• Prevention of Pancreatic Reactions by Bolus Somatostatin Administration in Patients Undergoing Endoscopic Retrograde Cholangio-Pancreatography and Endoscopic Sphincterotomy
  Hormone Research, 1988
• Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat
  British Journal of Surgery, 1985
• Effect of somatostatin on the pancreatitis-like biochemical changes due to endoscopic pancreatography: Preliminary report
  Metabolism, 1978
• Somatostatin therapy of acute experimental pancreatitis.
  Gut, 1977